ASTRAZENECA PLC SPON ADR EACH REP 0.50 ORD SHS (AZN) - Price, trends, fundamentals and chart - Passport to Wall Street

ASTRAZENECA PLC SPON ADR EACH REP 0.50 ORD SHS (NASDAQ: AZN)

Overview

current price

$66.29

$66.29

change

0.00 | 0.00%

0.00 | 0.00%

Yesterday's Close

66.29

open

0.00

volume

0.01 M

30d. avg volume.

6.70 M

1 day

0.00 - 0.00

52 weeks

61.24 - 87.68

p/e

14.73

beta

0.4853

market cap

205.58 B

dividend yield

2.29%

Industry

-

News and Commentary

Pharma Industry Faces Jitters As Trump Hints At Historic Tariffs, BofA Outlines Probable Timeline U.S. President Donald Trump, on Tuesday, disclosed plans for a "major tariff" on foreign pharmaceuticals."We're going to be announcing very shortly a ma...

Big Money Is Betting On Europe, Should You? 3 ETFs To Watch European fund managers are optimistic that rising economic growth will fuel a rally in the region's stocks.This bullishness is already reflected in perf...

Popular Ozempic, Wegovy Selected For Next Round Of Medicare Drug Price Negotiations On Friday, the U.S. Department of Health and Human Services (HHS) unveiled the selection of 15 additional drugs covered under Medicare Part D for price negotiations, building on...

AstraZeneca Lifts 2024 Forecast On Better Than Expected Q3 Performance, Says It Takes China Investig... AstraZeneca Plc (AZN&nb...

Market Update: Stocks Soar Higher as Postelection Rally Continues Stocks rose higher on Monday as the market's postelection rally continued. The Dow Jones Industrial Average climbed over 300 points to close above 44,000 for the first time, whil...

AstraZeneca Threatens To Move Vaccine Production Amid Reduced State Support AstraZeneca Plc (AZN&nb...

Market Update: Dow Falls 500 Points, S&P 500, Nasdaq Sink Lower Investors staged a broader market sell-off on Wednesday as underwhelming earnings reports from Alphabet and Tesla pulled the S&P 500 Index and Nasdaq Composite down to their wors...

Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment AstraZeneca PLC (AZN&nb...

Pfizer Wins $107.5M Verdict Against AstraZeneca Over Cancer Drug Patent Dispute A Delaware federal jury has determined that AstraZeneca Plc

AstraZeneca's COVID-19 Prevention Therapy Cuts Risk Of Infection In Patients With Weaker Immunity, D... Thursday, AstraZeneca Plc (AZN...

StockTwits

StockTwits